This report provides a national overview on diagnosed osteoporosis, related fractures and the osteoporosis care gap among Canadians 40 years and older.  It reports on administrative data from the Canadian […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

BISPHOSPHONATES The most common family of drugs used to treat osteoporosis Bisphosphonates are the most common family of drugs used to treat osteoporosis. They are part of the group of […]

Romosozumab EVENITY™ (romosozumab injection) Romosozumab, a sclerostin inhibitor, is the first new approach to the treatment of osteoporosis and fracture risk in almost a decade.Romosozumab (EVENITY™) significantly and rapidly (over […]

SIGNS AND SYMPTOMS A disease that develops without any symptoms. The First Warning Sign of Osteoporosis is Frequently A Fracture Osteoporosis is a disease that takes years to develop without […]

Healthcare Providers Guideline and Recommendations Find information and links to the 2023 Clinical Practice Guideline and Exercise and Long-Term Care Recommendations. Learn about Osteoporosis Canada’s Scientific Advisory Council (SAC). VIEW […]

ABOUT THE DISEASE What is Osteoporosis? Osteoporosis is a disease that slowly, quietly weakens bones, often going undiagnosed – even when it breaks them. Osteoporosis is caused by low bone […]

Zoe Bond, Dana Li and Rebecca Wills Diabetes and Fracture Risk Diabetes mellitus, commonly known as diabetes, is a condition that affects the hormone insulin, resulting in high blood sugar […]